Indian API Manufacturer Called Out for Numerous Violations

Drug GMP Report
A A
The FDA cited Reliance Life Sciences for a long list of deficiencies observed during an inspection of the API manufacturer’s facility in Navi Mumbai in December.

To View This Article:

Login

Subscribe To Drug GMP Report